Dicot AB
Dicot Pharma AB engages in the development of pharmaceutical products in Sweden. It develops LIB-01 for the treatment of erectile dysfunction and premature ejaculation. The company was formerly known as Dicot AB (publ) and changed its name to Dicot Pharma AB in May 2024. Dicot Pharma AB was incorporated in 2015 and is based in Uppsala, Sweden.
Dicot AB (DICOT) - Total Liabilities
Latest total liabilities as of December 2025: Skr12.10 Million SEK
Based on the latest financial reports, Dicot AB (DICOT) has total liabilities worth Skr12.10 Million SEK as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Dicot AB - Total Liabilities Trend (2021–2025)
This chart illustrates how Dicot AB's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Dicot AB Competitors by Total Liabilities
The table below lists competitors of Dicot AB ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
SDCL EDGE Acquisition Corporation
NYSE:SEDA-UN
|
USA | $110.33 Million |
|
The BORN Korea
KO:475560
|
Korea | ₩79.81 Billion |
|
SPARQ Corp.
OTCQB:SPRQF
|
USA | $801.55K |
|
SKY Metals Ltd
AU:SKY
|
Australia | AU$1.48 Million |
|
Bonraybio Co., Ltd.
TW:6955
|
Taiwan | NT$50.28 Million |
|
Sriracha Construction Public Company Limited
BK:SRICHA
|
Thailand | ฿1.58 Billion |
|
Surrozen Inc
NASDAQ:SRZN
|
USA | $117.56 Million |
Liability Composition Analysis (2021–2025)
This chart breaks down Dicot AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 7.07 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.16 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.14 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Dicot AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Dicot AB (2021–2025)
The table below shows the annual total liabilities of Dicot AB from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr12.10 Million | +1.21% |
| 2024-12-31 | Skr11.96 Million | +30.48% |
| 2023-12-31 | Skr9.16 Million | +30.64% |
| 2022-12-31 | Skr7.01 Million | +105.01% |
| 2021-12-31 | Skr3.42 Million | -- |